FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083694 [Registered on: 28/03/2025] Trial Registered Prospectively
Last Modified On: 26/03/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   Comparison of blood pressure, heart rate and pain suppression ability of two different local anaesthetic drugs i.e. lidocaine and levobupivacaine used in patients undergoing pituitary tumor surgeries via nasal route. 
Scientific Title of Study   Comparison of hemodynamic stability and analgesic efficacy of topical intranasal lidocaine versus levobupivacaine in patient undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary tumour surgeries: A prospective randomized double blind study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Shameer imam 
Designation  DM First year (Senior Resident) 
Affiliation  Mahatma gandhi medical college and hospital jaipur 
Address  ROOM NO.208 SABARMATI HOSTEL OPP BURGER FARM MAHATMA GANDHI MEDICAL COLLEGE JAIPUR
Department of Neuroanaesthesia fourth floor SRMC building MAHATMA GANDHI MEDICAL COLLEGE JAIPUR
Jaipur
RAJASTHAN
202002
India 
Phone  8127553526  
Fax    
Email  shamimam00@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sunita Sharma 
Designation  Professor and Head Of Department 
Affiliation  Mahatma gandhi medical college and hospital jaipur 
Address  Department of Neuroanaesthesia fourth floor SRMC building MAHATMA GANDHI MEDICAL COLLEGE JAIPUR

Jaipur
RAJASTHAN
302022
India 
Phone    
Fax    
Email  drsunitakhs@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Sunita Sharma 
Designation  Professor and Head Of Department 
Affiliation  Mahatma gandhi medical college and hospital jaipur 
Address  Department of Neuroanaesthesia fourth floor SRMC building MAHATMA GANDHI MEDICAL COLLEGE JAIPUR

Jaipur
RAJASTHAN
302022
India 
Phone    
Fax    
Email  drsunitakhs@yahoo.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Medical College and Hospital Jaipur RIICO Institutional Area, Sitapura,Tonk Road, Jaipur- pin code (302 022 ) (Rajasthan)  
 
Primary Sponsor  
Name  Mahatma Gandhi Medical College and Hospital Jaipur 
Address  RIICO Institutional Area,Sitapura, Tonk Road, Jaipur - 302 022 (Rajasthan) INDIA 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shameer Imam  Mahatma Gandhi Medical College and Hospital Jaipur  4th floor Sri Ram Cancer Center OT Complex Department of Neuroanesthesia
Jaipur
RAJASTHAN 
8127553526

shamimam00@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Ethics Committee, Mahatma Gandhi Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G00-G99||Diseases of the nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  levobupivacaine group  Patients undergoing the study were randomly assigned to receive intranasal packing with 15 mL of 0.5% levobupivacaine combined with 60mg of ephedrine (2 mL) Prior to the surgical procedure, the study drug vial was provided to the scrub nurse by the principal investigator. The scrub nurse then prepared the packing solution by mixing the study drug with 60 mg of ephedrine (2 mL) in a sterile manner. Subsequently, six standard-sized packing gauzes were thoroughly soaked in the prepared solution and carefully inserted into both nasal cavities immediately after the patient was intubated. The intranasal gauze packs remained in place for a duration of 20 minutes, coinciding with the time taken for the patient to be prepped and draped for the surgical procedure. After this period, the packs were removed to facilitate the commencement of the operation 
Comparator Agent  lidocaine group  Patients undergoing the study were randomly assigned to receive intranasal packing with 15 mL of 1.5% lidocaine combined with 60mg of ephedrine (2 mL) Prior to the surgical procedure, the study drug vial was provided to the scrub nurse by the principal investigator. The scrub nurse then prepared the packing solution by mixing the study drug with 60 mg of ephedrine (2 mL) in a sterile manner. Subsequently, six standard-sized packing gauzes were thoroughly soaked in the prepared solution and carefully inserted into both nasal cavities immediately after the patient was intubated. The intranasal gauze packs remained in place for a duration of 20 minutes, coinciding with the time taken for the patient to be prepped and draped for the surgical procedure. After this period, the packs were removed to facilitate the commencement of the operation 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients aged between 18 to 65 years.
2. Both male and female patients.
3. American Society of Anesthesiologists physical class 2 or 3.
4. Scheduled for endoscopic binostril transnasal transsphenoidal (TNTS) surgery.
5. Diagnosis of sellar or suprasellar tumors.
 
 
ExclusionCriteria 
Details  1. Refusal to provide informed consent.
2. Preoperative cerebrospinal fluid leak.
3. Known allergy to local anesthetic agents.
4. Preoperative cardiac arrhythmias.
5. History of seizure disorders.
6. Pregnancy.
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the hemodynamic changes between both groups and report adverse effects if any.

 
3 min,(Post tracheal intubation),At insertion of endoscope,3 min. later, At start of mucosal dissection,1 min/2min/3min/4min/5min,10 min,20 min,30 min,40 min,50 min,60 min,1hr 30 min,2 hr,2hr 30 min,3hr.,At tracheal extubation
 
 
Secondary Outcome  
Outcome  TimePoints 
To compare intraoperative bleeding in the surgical field between both groups.
 
Boezaart surgical field Grade 1 ,2,3,4,5 
To compare the time to extubation of patients between both groups.  Time to be recorded from the time of stopping the inhalation agent till the removal of endotracheal tube 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Type of Study – Hospital based prospective randomized double blind study.

Period of Study – 18 months from the day of approval.

Place of study – Dept.of NeuroAnaesthesiology, Mahatma Gandhi Medical College and Hospital, Jaipur

Procedure/Method:

Patients undergoing the study were randomly assigned to receive intranasal packing with either 15 mL of 1.5% lidocaine or 15 mL of 0.5% levobupivacaine, both combined with 60mg of ephedrine (2 mL). This randomization process was carried out through stratified block randomization, ensuring an equal distribution of study drugs. The allocation was conducted by a biostatistician who was independent of the study using the Statistical Analysis System software. The sequence of randomization was then communicated to the pharmacist responsible for packaging the drugs. These drugs were carefully packaged in amber colored bottles, which were labeled numerically in accordance with the randomization sequence.

To maintain blinding throughout the study, neither the patients nor the investigators were aware of the assigned treatment. The randomization code was securely kept confidential in the pharmacy department until it was disclosed at the conclusion of the study. Prior to the surgical procedure, the appropriate study drug vial was provided to the scrub nurse by the principal investigator. The scrub nurse then prepared the packing solution by mixing the study drug with 60 mg of ephedrine (2 mL) in a sterile manner. Subsequently, six standard-sized packing gauzes were thoroughly soaked in the prepared solution and carefully inserted into both nasal cavities immediately after the patient was intubated.

The intranasal gauze packs remained in place for a duration of 20 minutes, coinciding with the time taken for the patient to be prepped and draped for the surgical procedure. After this period, the packs were removed to facilitate the commencement of the operation. Throughout this entire process, strict adherence to blinding protocols was maintained to prevent any bias in the study outcomes.

 
Close